APA način citiranja

Sharman, J., Hawkins, M., Kolibaba, K., Boxer, M., Klein, L., Wu, M., . . . Yasenchak, C. (2015). An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia. Blood.

Čikaški stil citiranja

Sharman, Jeff, Michael Hawkins, Kathryn Kolibaba, Michael Boxer, Leonard Klein, Meihua Wu, Jing Hu, Steve Abella, i Chris Yasenchak. "An Open-label Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Chronic Lymphocytic Leukemia." Blood 2015.

MLA način citiranja

Sharman, Jeff, et al. "An Open-label Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Chronic Lymphocytic Leukemia." Blood 2015.